title: Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma.
abstract: Toll-like receptors (TLRs) are immunological receptors recognizing various microbial and endogenous ligands, such as DNA, RNA, and other microbial and host components thus activating immunological responses. The expression of TLRs in esophageal adenocarcinoma is not well known. The aim of this study was to evaluate expression patterns of those TLRs that sense nucleic acids in Barrett's esophagus with and without dysplasia and in esophageal adenocarcinoma. TLRs 3, 7 and 8 were stained immunohistochemically and evaluated in a cohort of patients with esophageal adenocarcinoma or dysplasia. Specimens with normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n = 42) or high-grade dysplasia (n = 37) and esophageal adenocarcinoma (n = 99) were studied. We used immunofluorescence to confirm the subcellular localization of TLRs. We found abundant expression of TLR3, 7 and 8 in esophageal squamous epithelium, columnar metaplasia, dysplasia and adenocarcinoma. Cytoplasmic expression of TLR3, TLR7 or TLR8 did not associate to clinicopathological parameters or prognosis in esophageal cancer. High nuclear expression of TLR8, confirmed with immunofluorescence, in cancer cells was observed in tumors of high T-stage (p < 0.01) and in tumors with organ metastasis (p < 0.001). High nuclear TLR8 expression was associated with poor prognosis (p < 0.001). The expression of TLR3, TLR7 and TLR8 increased toward dysplasia and adenocarcinoma. We demonstrated nuclear localization of TLR8, which associates with metastasis and poor prognosis. TLR3 and TLR7 do not seem to have prognostic significance in esophageal adenocarcinoma.
authors.affiliation: Department of Pathology, University of Oulu, Oulu, Finland; Department of Surgery, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland.
authors.forename: Olli
authors.initials: O
authors.lastname: Helminen
authors.affiliation: Department of Pathology, University of Oulu, Oulu, Finland; Department of Surgery, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland.
authors.forename: Heikki
authors.initials: H
authors.lastname: Huhta
authors.affiliation: Department of Surgery, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland; Department of Anatomy and Cell Biology, University of Oulu, Oulu, Finland.
authors.forename: Petri P
authors.initials: PP
authors.lastname: Lehenkari
authors.affiliation: Department of Surgery, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland.
authors.forename: Juha
authors.initials: J
authors.lastname: Saarnio
authors.affiliation: Department of Pathology, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland.
authors.forename: Tuomo J
authors.initials: TJ
authors.lastname: Karttunen
authors.affiliation: Department of Pathology, University of Oulu, Oulu, Finland; Department of Surgery, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu, Finland; Oulu University Hospital, Oulu, Finland.
authors.forename: Joonas H
authors.initials: JH
authors.lastname: Kauppila
keywords: Barrett’s esophagus; esophageal adenocarcinoma; esophageal cancer; toll-like receptor 3; toll-like receptor 7; toll-like receptor 8